Literature DB >> 15372235

Expression of proteins related to prostaglandin E2 biosynthesis is increased in human gastric cancer and during gastric carcinogenesis.

Tae Jung Jang1.   

Abstract

Prostaglandin E2 (PGE2) is related to carcinogenesis. Cyclooxygenase (COX) and prostaglandin E synthase (PGES) are involved in PGE2 synthesis. However, overall situation of COX and microsomal PGES (mPGES) expression in gastric cancer has not been studied in detail. The expression of COX and mPGES was evaluated in 45 cases of gastric cancer (22 intestinal type and 23 diffuse type), 13 gastric dysplasia, 15 intestinal metaplasia, 18 Helicobacter pylori associated gastritis, and 10 normal gastric tissues by performing immunohistochemistry and Western blot analysis. COX-1 expression was higher in intestinal type cancers than diffuse ones. COX-2 and mPGES-1 were expressed more in cancers than in paired nonneoplastic adjacent tissues, and intestinal type cancers showed higher expression of COX-2 than diffuse ones. The expression of COX and mPGES was gradually increased with progression of gastric lesions and the highest in dysplasia. mPGES-1 was expressed not only in epithelial cells but also in stromal cells, whose phenotype was myofibroblast, endothelial cells and others. In conclusion, proteins related to PGE2 biosynthesis affect both histogenesis and the carcinogenesis of human gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372235     DOI: 10.1007/s00428-004-1104-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  42 in total

1.  Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.

Authors:  Tae Jung Jang; Ho Guen Jung; Ki Hoon Jung; Min Ku O
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

2.  Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells.

Authors:  D O Stichtenoth; S Thorén; H Bian; M Peters-Golden; P J Jakobsson; L J Crofford
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

3.  Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.

Authors:  K Watanabe; T Kawamori; S Nakatsugi; T Ohta; S Ohuchida; H Yamamoto; T Maruyama; K Kondo; F Ushikubi; S Narumiya; T Sugimura; K Wakabayashi
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

4.  Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.

Authors:  P C Chulada; M B Thompson; J F Mahler; C M Doyle; B W Gaul; C Lee; H F Tiano; S G Morham; O Smithies; R Langenbach
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

5.  Identification and characterization of a novel type of membrane-associated prostaglandin E synthase.

Authors:  Naomi Tanikawa; Yoshihiro Ohmiya; Hiroaki Ohkubo; Katsuyuki Hashimoto; Kenji Kangawa; Masami Kojima; Seiji Ito; Kikuko Watanabe
Journal:  Biochem Biophys Res Commun       Date:  2002-03-08       Impact factor: 3.575

6.  Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer.

Authors:  Rajnish A Gupta; Lovella V Tejada; Beverly J Tong; Sanjoy K Das; Jason D Morrow; Sudhansu K Dey; Raymond N DuBois
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

7.  Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2.

Authors:  Makoto Murakami; Karin Nakashima; Daisuke Kamei; Seiko Masuda; Yukio Ishikawa; Toshiharu Ishii; Yoshihiro Ohmiya; Kikuko Watanabe; Ichiro Kudo
Journal:  J Biol Chem       Date:  2003-06-30       Impact factor: 5.157

8.  Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells.

Authors:  Ximing Tang; Yun Jie Sun; Elizabeth Half; M Tien Kuo; Frank Sinicrope
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

9.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

Authors:  M Tsujii; S Kawano; R N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis.

Authors:  Tomohiro Kitamura; Toshihiko Kawamori; Naoaki Uchiya; Masaki Itoh; Tetsuo Noda; Mamoru Matsuura; Takashi Sugimura; Keiji Wakabayashi
Journal:  Carcinogenesis       Date:  2002-09       Impact factor: 4.944

View more
  11 in total

1.  Cyclooxygenase-2 expression and effect of celecoxib in flurothyl-induced neonatal seizure.

Authors:  Doo Kwun Kim; Tae Jung Jang
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

2.  NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cells.

Authors:  Xiaoxu Zhou; Dan Li; Murray B Resnick; Jack Wands; Weibiao Cao
Journal:  Mol Pharmacol       Date:  2013-02-25       Impact factor: 4.436

3.  Immunoexpression of cyclooxygenase-2 in primary gastric carcinomas and lymph node metastases.

Authors:  Paulo R C Almeida; Francisco V A Ferreira; Cássio C Santos; Francisco D Rocha-Filho; Raul R R P Feitosa; Esther A A Falcão; Belise K Cavada; Roberto C P Lima-Júnior; Ronaldo A Ribeiro
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

Review 4.  Identification and development of mPGES-1 inhibitors: where we are at?

Authors:  Hui-Hua Chang; Emmanuelle J Meuillet
Journal:  Future Med Chem       Date:  2011-11       Impact factor: 3.808

Review 5.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 6.  Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?

Authors:  Zhongxing Liao; Kathryn A Mason; Luka Milas
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Epstein-Barr virus-specific methylation of human genes in gastric cancer cells.

Authors:  Julie L Ryan; Richard J Jones; Shannon C Kenney; Ashley G Rivenbark; Weihua Tang; Elizabeth Rw Knight; William B Coleman; Margaret L Gulley
Journal:  Infect Agent Cancer       Date:  2010-12-31       Impact factor: 2.965

8.  Gastric juice prostaglandins and peptide growth factors as potential markers of chronic atrophic gastritis, intestinal metaplasia and gastric cancer: their potential clinical implications based on this pilot study.

Authors:  Ajoy Dias; Cesar Garcia; Marek Majewski; Grzegorz Wallner; Richard W McCallum; Cezary Poplawski; Jerzy Sarosiek
Journal:  Dig Dis Sci       Date:  2011-06-22       Impact factor: 3.199

9.  Decreased expression of 15-hydroxyprostaglandin dehydrogenase in gastric carcinomas.

Authors:  Tae Jung Jang; Ye Seob Ji; Ki Hoon Jung
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

10.  Relationship between 15-hydroxyprostaglandin dehydrogenase and gastric adenocarcinoma.

Authors:  Jae Hyun Kang; Sang Hyun Kang; Sang Hyuk Seo; Jae Ho Shin; Min Sung An; Tae Kwun Ha; Ki Beom Bae; Tae Hyun Kim; Chang Soo Choi; Sang Hoon Oh; Mi Seon Kang; Kwang Hee Kim
Journal:  Ann Surg Treat Res       Date:  2014-05-23       Impact factor: 1.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.